P, P., SR, M., AD, D., HP, R., AH, P., A, P., . . . QD, C. (2019). Utility of routine pretreatment evaluation of left ventricular ejection fraction in breast cancer patients receiving anthracyclines. The breast journal, 25(1), 62. https://doi.org/10.1111/tbj.13182
Chicago Style (17th ed.) CitationP, Peddi, et al. "Utility of Routine Pretreatment Evaluation of Left Ventricular Ejection Fraction in Breast Cancer Patients Receiving Anthracyclines." The Breast Journal 25, no. 1 (2019): 62. https://doi.org/10.1111/tbj.13182.
MLA (9th ed.) CitationP, Peddi, et al. "Utility of Routine Pretreatment Evaluation of Left Ventricular Ejection Fraction in Breast Cancer Patients Receiving Anthracyclines." The Breast Journal, vol. 25, no. 1, 2019, p. 62, https://doi.org/10.1111/tbj.13182.